Pruritus Therapeutics Global Market Types and Applications, Drivers, Ongoing Trends, Future Demand, Challenges, Top Companies And Forecast 2024-2033

The pruritus therapeutics market size has grown strongly in recent years. It will grow from $11.39 billion in 2023 to $12.03 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to growth in incidence of pruritus, diverse causes and conditions, rising aging population, patient quality of life focus..

The pruritus therapeutics market size is expected to see strong growth in the next few years. It will grow to $14.99 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to expanding knowledge of pruritus pathophysiology, innovative drug formulations and delivery, focus on personalized medicine, rise in dermatological research and development, increasing awareness and diagnosis rates, growing interest in botanical and herbal remedies. Major trends in the forecast period include development of itch-specific receptor agonists and antagonists, market emphasis on personalized therapeutic approaches, integration of technology in itch monitoring and management, collaborations for cross-disciplinary research..

Market Overview -
Pruritus therapeutics refers to the treatments used to address an unpleasant skin sensation that causes an urge to scratch. This treatment is commonly used to stop swelling and inflammation in moderate-to-severe inflammatory skin diseases.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=11907&type=smp

Surge In Dermatological Disorders Fuels Pruritus Therapeutics Market Growth
The rise in the incidence of dermatological disorders is expected to propel the growth of the pruritus therapeutics market going forward. Dermatological disorders refer to skin, hair, nail, and mucous membrane disorders ranging from acne and eczema to skin cancer and fungal infections. The underlying cause of itching often determines the use of pruritus treatments for dermatological illnesses. This condition uses topical treatments, emollients and moisturizers, immunosuppressant medications, and itching medications. For instance, in January 2022, according to the report published by the American Cancer Society Inc., a US-based voluntary organization for cancer awareness, the estimated cases of skin cancer increased to 108,480106,110 in 2021 , an increase of 5.8% from 100,350 in 2020. Therefore, the rise in the incidence of dermatological disorders is driving the growth of the pruritus therapeutics market.

Competitive Landscape -
Major companies operating in the pruritus therapeutics market report are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Eli Lilly and Company, Amgen Inc. , Regeneron Pharmaceuticals Inc., Astellas Pharma Inc. , Bausch Health Companies Inc., Brunswick Corporation, Galderma Laboratories LP, Cipla Limited, Vifor Pharma Ltd., Carl Zeiss Meditec AG, LEO Pharma AS, Mirum Pharmaceuticals Inc., Cara Therapeutics Inc., GlaxoSmithKline Plc, Novan Inc., Escient Pharmaceuticals Inc., Nerre Therapeutic Ltd., EPI Health LLC, Trevi Therapeutics Inc., Evelo Biosciences, Toray Medical Co. Ltd.

Innovative Therapies Drive Progress In Pruritus Treatment
Product innovation is a key trend gaining popularity in the pruritus therapeutics market. Major companies operating in the pruritus therapeutics market focused on developing novel products to strengthen their position in the market. For instance, in August 2021, Fresenius Medical Care AG & Co., a Germany-based product and service provider for people with kidney illnesses, launched KORSUVA (difelikefalin) for a reduction of pruritus related to chronic kidney dysfunction (CKD-aP) in adults having hemodialysis. The Food and Drug Administration (FDA) approved a novel therapeutic injectable drug for managing moderate-to-severe pruritis in patients receiving hemodialysis due to chronic renal failure. It is a first-in-class kappa opioid receptor (KOR) that targets the outer neurological system of the human body. It enhances the safety or effectiveness of the treatment, diagnosis, or prevention of crucial illnesses compared to standard applications.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-report

Key Segments -
The pruritus therapeutics market covered in this report is segmented -
1) By Product: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressants, Calcineurin Inhibitors, Other Products
2) By Route of Administration: Oral, Parenteral, Topical
3) By Disease Type: Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types
4) By End-User: Hospitals, Clinics, Other End Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.